Search Results 291-300 of 23893 for prostate cancer
Castration-resistant prostate cancer patients with rising prostatic specific antigen (PSA) are eligible for this study. 11C-Choline PET/CT will be used to ...
The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene ...
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer. Print details. Share; Facebook · Twitter. Overview; Participation eligibility ...
... prostate cancer patients. Cancer Epidemiol. 2025 Apr; 95:102769 Epub 2025 Feb 12. View PubMed; Yap JQ, Riggan KA, Cobran EK, Halyard MY, James SE, Kelly MK ...
Testicles produce sperm. Fluid from the seminal vesicles and prostate gland mixes with sperm to make semen. The penis ejaculates semen during sexual activity.
... prostate cancer. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
With some special help from his doctors, Tommy. Archer outraced prostate cancer in order to be there. Here's Dennis Douda for the Mayo Clinic News. Network ...
The study also seeks to further characterize (as possible) any other serious adverse reaction(s) in the long-term in adults with prostate cancer who received at ...
... cancer cells survive after androgen ablation, the most common therapy for advanced prostate cancer. Prostate cancer is initially an androgen-dependent tumor.
Active surveillance for prostate cancer, also called "expectant management" or "watchful waiting," is used to avoid treatment side effects in men with a low ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.